Trial intelligence / Profile preview

Prednisone for Acute Exacerbations of COPD in General Practice

NCT02330952Phase 4Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Feb 2015
Primary completion
May 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of prednisone in chronic obstructive pulmonary disease (COPD), sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2015; status: completed.

02

Drugs

prednisone
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT02330952.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02330952.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call